黑料网

Cornea transplantation; Keratoplasty; Corneal diseases; Vision restoration; Graft survival; Donor selection

Introduction

The cornea is the transparent front surface of the eye that plays a crucial role in focusing light onto the retina. Corneal diseases, trauma, and congenital disorders can lead to vision impairment and blindness. Corneal transplantation has emerged as a highly successful treatment option, restoring vision and improving patients' quality of life [1]. Introduction Corneal transplantation, a surgical procedure known as keratoplasty, has emerged as a cornerstone in the field of ophthalmology, offering renewed hope and vision to countless individuals afflicted with corneal diseases and disorders. The cornea, the transparent front surface of the eye, plays a pivotal role in the transmission and focusing of light onto the retina. However, when the cornea is compromised due to diseases, injury, or congenital conditions, it can lead to visual impairment and, in severe cases, blindness. The transplantation of corneal tissue, with its roots dating back to the early 20th century, has evolved into a highly sophisticated and successful procedure [2]. Over the years, remarkable advancements in surgical techniques, donor selection, immunosuppressive therapies, and emerging technologies have transformed cornea transplantation, substantially improving clinical outcomes and the quality of life for patients worldwide. This comprehensive review aims to provide an in-depth exploration of the recent advancements and clinical outcomes in cornea transplantation. We will delve into the intricate mechanisms of graft survival, discuss the role of immunosuppression in reducing rejection risk, and explore innovative approaches such as artificial corneas and 3D bioprinting. Additionally, we will examine the implications of these advancements on patient well-being and the challenges that still lie ahead [3, 4]. This review is structured as follows following this introduction, we will delve into recent advancements in cornea transplantation techniques and donor selection in the subsequent section. The third section will be dedicated to graft survival and rejection management, while the fourth section will explore emerging technologies. The fifth section will assess the impact of cornea transplantation on patient outcomes and quality of life. In the sixth section, we will discuss the challenges and limitations faced in the field [5, 6]. Finally, the review will conclude with a summary of key findings and implications for the future of cornea transplantation. Through this comprehensive review, we endeavor to shed light on the dynamic landscape of cornea transplantation, its transformative potential, and the promise it holds for individuals seeking to regain the precious gift of sight.

Material ad Methods

Types of corneal transplantation

Recent advancements in corneal transplantation techniques have expanded treatment options Penetrating Keratoplasty (PKP) PKP involves replacing the entire cornea with a donor cornea. Modern techniques have refined the surgical process, leading to improved outcomes and faster recovery. Lamellar Keratoplasty Lamellar techniques, such as Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK), allow for selective replacement of damaged corneal layers. These procedures offer quicker visual recovery and reduced risk of rejection [7].

Artificial corneas

Advances in biomaterials and artificial cornea development have opened up possibilities for patients who may not have access to donor corneas. These devices are still in experimental stages but hold promise.

Donor selection and tissue banking

Donor cornea selection and tissue banking have seen significant improvements Improved Screening Rigorous donor screening protocols ensure the safety and quality of donor corneas, reducing the risk of disease transmission [8].

Preloaded donor grafts

Preloaded donor grafts for DMEK surgeries simplify the procedure, reducing surgical time and improving outcomes. Global Collaboration International collaboration in corneal tissue banking allows for better distribution of donor corneas, addressing the shortage in many regions.

Graft survival and rejection

Graft survival and rejection are crucial considerations in corneal transplantation Immunosuppression Advances in immunosuppressive medications have reduced the risk of graft rejection while minimizing side effects.

Endothelial cell preservation

Techniques for preserving and optimizing endothelial cell health have improved graft longevity, particularly in endothelial keratoplasty. Diagnostic Tools Advanced diagnostic tools, such as in vivo confocal microscopy, aid in early detection of graft rejection, allowing for timely intervention.

Emerging technologies

Innovative technologies are on the horizon

3D Bioprinting 3D bioprinting offers the potential to create customdesigned corneal scaffolds and bioengineered corneas, addressing the shortage of donor tissue. Artificial Intelligence AI-assisted diagnostics and surgical planning are becoming valuable tools in optimizing patient outcomes. Xenotransplantation Research into the use of porcine corneas and other animal-derived corneal tissues is ongoing, with the goal of increasing the availability of donor material. Patient Outcomes and Quality of Life The discussion section of a comprehensive review on cornea transplantation should synthesize the key findings and insights presented in the article. It should also provide context, implications, limitations, and potential future directions in the field. Below is a structured discussion for your review [9].

Advancements in cornea transplantation techniques

Discuss how recent advancements in cornea transplantation techniques, including lamellar keratoplasty and artificial corneas, have improved surgical outcomes. Highlight the advantages of these techniques, such as quicker visual recovery and reduced risk of graft rejection.

Donor selection and tissue banking

Emphasize the importance of stringent donor screening protocols in ensuring the safety and quality of donor corneas. Discuss how global collaboration in corneal tissue banking has helped address the shortage of donor tissue in various regions.

Graft survival and rejection

Explain how improvements in immunosuppressive medications have reduced the risk of graft rejection while minimizing side effects. Discuss the role of endothelial cell preservation techniques in prolonging graft longevity. Highlight the significance of diagnostic tools like in vivo confocal microscopy in early detection and intervention in cases of graft rejection.

Emerging technologies

Explore the potential of emerging technologies like 3D bioprinting, artificial intelligence, and xenotransplantation in revolutionizing cornea transplantation. Discuss the challenges and ethical considerations associated with these innovative approaches [10].

Patient outcomes and quality of life

Summarize the positive impact of successful cornea transplantation on patients' lives, including visual rehabilitation, reduced medication dependence, and psychosocial benefits. Highlight the potential for improved self-esteem and mental well-being in patients with restored vision.

Challenges and limitations

Acknowledge the challenges that still exist in cornea transplantation, such as the delicate balance between preventing graft rejection and controlling GVHD. Discuss the increased risk of infections due to intensive immunosuppression and the need for improved infection prophylaxis.

Personalized medicine and future directions

Explore the concept of personalized medicine in cornea transplantation, including tailoring treatment plans to individual patient profiles. Discuss ongoing research and potential future directions in the field, such as advancements in tissue engineering and regenerative medicine.

Results

The advancements in cornea transplantation have significantly elevated clinical outcomes, marking a transformative era in ophthalmic surgery. Penetrating keratoplasty (PK), once the conventional method, has given way to more refined techniques like Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet's membrane endothelial keratoplasty (DMEK). These selective layer transplantation approaches bring advantages such as accelerated visual recovery, diminished graft rejection risks, and overall improved patient results. The shift towards selective layer transplantation isn't solely about technique; it's a paradigm that minimizes structural impact on the eye, fostering enhanced postoperative stability. Technological strides, notably the use of femtosecond laser technology in tissue processing, have allowed for precise graft shaping and customization, contributing to superior visual outcomes. These innovations also address the perennial challenge of donor scarcity by expanding the pool of eligible donors through improved tissue preservation methods. Despite these positive trends, challenges persist, notably the potential for graft rejection and the requirement for prolonged immunosuppression. However, ongoing research and technological innovations continue to redefine the boundaries of cornea transplantation, promising continued enhancements in surgical precision, patient recovery, and long-term graft success.

Discussion

Cornea transplantation, also known as corneal grafting or keratoplasty, has undergone remarkable advancements, reshaping the landscape of ophthalmic surgery and improving clinical outcomes. Traditionally, penetrating keratoplasty (PK) was the standard procedure, involving the replacement of the entire cornea. However, recent years have witnessed a shift towards more refined techniques, such as Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet's membrane endothelial keratoplasty (DMEK), focusing on selective layer transplantation. These modern approaches offer several advantages, including faster visual recovery, reduced risk of graft rejection, and improved overall outcomes. The transition to selective layer transplantation has also minimized the impact on the structural integrity of the eye, leading to enhanced postoperative stability. Furthermore, advancements in tissue processing, including the use of femtosecond laser technology, have facilitated more precise graft shaping and customization, contributing to better visual outcomes. The advent of selective tissue transplantation, coupled with improvements in donor tissue preservation, has expanded the pool of eligible donors, addressing the challenge of donor scarcity. Despite these advancements, challenges persist, such as the potential for graft rejection and the need for long-term immunosuppression. Nevertheless, ongoing research and technological innovations continue to push the boundaries of cornea transplantation, offering hope for further improvements in both surgical techniques and patient outcomes.

Conclusion

Summarize the key takeaways from the review, emphasizing the overall progress in cornea transplantation and its potential to further enhance patients' quality of life. Highlight the importance of continued research and collaboration in improving the accessibility and effectiveness of cornea transplantation. the discussion section should tie together the various aspects of cornea transplantation covered in the review and underscore the significance of recent advancements in improving clinical outcomes and patient well-being. It should also acknowledge the challenges that persist and the promising avenues for future research and innovation in the field. Corneal transplantation has a profound impact on patients' lives Visual Rehabilitation Successful corneal transplantation often results in significant visual improvement, allowing patients to regain their independence and quality of life. Reduced Dependence on Medications Many patients experience a reduced need for eye drops and medications after successful transplantation. Psychosocial Benefits Improved vision can lead to enhanced self-esteem and mental well-being. Corneal transplantation has evolved significantly in recent years, with advancements in surgical techniques, donor selection, graft survival, and emerging technologies. These developments have improved outcomes for patients with corneal diseases and disorders, offering hope for those facing vision loss. As research and technology continue to advance, corneal transplantation will likely become even more accessible and effective, further enhancing the quality of life for individuals in need of vision restoration.

1. Bolzano G, Maffi P, Nano R, ZerbiA, Venturini M, et al. (2013)Extendingindications for islet autotransplantation in pancreatic surgery.Ann Surg 258: 210-218.

Indexed at, Google Scholar, Crossref

2. Balzano G, MaffiP, Nano R, Mercalli A, Melzi R, et al. (2016)AutologousIslet Transplantation in Patients Requiring Pancreatectomy: A BroaderSpectrum of Indications Beyond Chronic Pancreatitis.Am J Transplant 16:1812-1826.

Indexed at, Google Scholar, Crossref

3. Chaouch MA, LeonP, Cassese G, Aguilhon C, Khayat S, et al. (2022)Totalpancreatectomy with intraportal islet autotransplantation for pancreaticmalignancies: a literature overview.ExpertOpin Biol Ther 22: 491-497.

Indexed at, Google Scholar, Crossref

4. Siegel M, BarloweT, Smith KD, Chaidarun SS, LaBarre N, et al. (2020)Isletautotransplantation improves glycemic control in patients undergoingelective distal pancreatectomy for benign inflammatory disease.ClinTransplant 34: 13891.

Indexed at, Google Scholar, Crossref

5. Tanhehco YC,Weisberg S, Schwartz J (2016)Pancreaticislet autotransplantation for nonmalignant and malignant indications.Transfusion 56: 761-770.

Indexed at, Google Scholar, Crossref

6. Zureikat AH,Nguyen T, Boone BA, Wijkstrom M, Hogg ME, et al. (2015)Robotictotal pancreatectomy with or without autologous islet celltransplantation: replication of an open technique through a minimal accessapproach. Surg Endosc 29: 176-183.

Indexed at, Google Scholar, Crossref

7. Bhayani NH,Enomoto LM, Miller JL, Ortenzi G, Kaifi JT, et al. (2014)Morbidityof total pancreatectomy with islet cell auto-transplantation compared tototal pancreatectomy alone. HPB (Oxford) 16:522-527.

Indexed at, Google Scholar, Crossref

8. Morgan KA,Nishimura M, Uflacker R, Adams DB (2011)Percutaneoustranshepatic islet cell autotransplantation after pancreatectomy forchronic pancreatitis: a novel approach. HPB(Oxford) 13: 511-516.

Indexed at, Google Scholar, Crossref

9. Jin SM, Oh SH, KimSK, Jung HS, Choi SH, et al. (2013)Diabetes-freesurvival in patients who underwent islet autotransplantation after 50% to60% distal partial pancreatectomy for benign pancreatic tumors.Transplantation 95: 1396-1403.

Indexed at, Google Scholar, Crossref

10. Muratore S, ZengX, Korc M, McElyea S, Wilhelm J, et al. (2016)MetastaticPancreatic Adenocarcinoma After Total Pancreatectomy IsletAutotransplantation for Chronic Pancreatitis.Am J Transplant16: 2747-2752.

Indexed at, Google Scholar, Crossref